Metagenomi Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Cash & Equivalents	145.85	190.51	43.4
Short-Term Investments	130.58	177.69	68.86
Cash & Cash Equivalents	276.43	368.2	112.25
Cash Growth	-24.92%	228.01%	-
Receivables	2.45	0	0
Other Current Assets	-0.61	-1.31	-3.34
Total Current Assets	278.27	366.9	108.92
Property, Plant & Equipment	65.15	33.26	21.89
Long-Term Investments	10.68	7.81	6.42
Other Long-Term Assets	10.74	6.52	4.77
Total Long-Term Assets	86.57	47.59	33.08
Total Assets	364.84	414.49	141.99
Accounts Payable	1.79	2.01	1.35
Deferred Revenue	78.99	110.13	39.76
Current Debt	3.43	1.52	0.69
Other Current Liabilities	-15.35	-65.12	-16.63
Total Current Liabilities	68.86	48.54	25.17
Long-Term Debt	44.8	17.06	48.24
Other Long-Term Liabilities	36.01	77.22	24.63
Total Long-Term Liabilities	80.81	94.27	72.87
Total Liabilities	149.67	142.81	98.04
Total Debt	48.23	18.57	48.93
Debt Growth	159.70%	-62.04%	-
Retained Earnings	-144.94	-76.69	-33.1
Comprehensive Income	-0.1	-0.27	-0.02
Shareholders' Equity	-135.58	-74.43	-32.54
Net Cash / Debt	228.2	349.63	63.33
Net Cash / Debt Growth	-34.73%	452.12%	-
Net Cash Per Share	67.03	102.85	19.44
Working Capital	209.41	318.36	83.74
Book Value Per Share	-39.82	-21.89	-9.99

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).